SCHEMBL14219258

SCHEMBL14219258

CC(C)OC(=O)CNC(=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR139 Q6DWJ6 1/20 0.55
TSHR P16473 1/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
HTT P42858 2/20 0.53
LMNA P02545 2/20 0.53
ALDH1A1 P00352 1/20 0.53
GAA P10253 1/20 0.52
KMT2A Q03164 1/20 0.51
PRSS1 P07477 2/20 0.50
CTSG P08311 2/20 0.50
CTRB1 P17538 2/20 0.50
CMA1 P23946 2/20 0.50
MAPT P10636 1/20 0.50
GLA P06280 1/20 0.48
KDM4E B2RXH2 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
POLB P06746 1/20 0.47
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14219779 0.86 GPR139 (0.51) GPR139NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL3961994 0.82 GAA (0.59) GPR139TSHRNPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL9331679 0.81 GAA (0.57) GPR139TSHRNPC1RAB9ASMN1; SMN2
SCHEMBL5655365 0.80 PRSS1 (0.68) GPR139NPC1RAB9ASMN1; SMN2HTT
SCHEMBL9135411 0.80 GPR139 (0.51) GPR139NPC1RAB9ASMN1; SMN2HTT
SCHEMBL30539770 0.79 GAA (0.59) GPR139NPC1RAB9ASMN1; SMN2HTT
SCHEMBL29117026 0.78 PRSS1 (0.49) GPR139NPC1RAB9AGAAKMT2A
SCHEMBL11519981 0.78 GAA (0.53) GPR139NPC1RAB9ASMN1; SMN2HTT
SCHEMBL1221369 0.78 RAB9A (0.66) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL6084716 0.78 PTPRC (0.62) GPR139NPC1RAB9ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101095648-A Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds OREAL (FR) 2008-01-02 CN claimed
EP-1911438-A2 Cosmetic composition containing a derivative of dibenzoylmethane and a arylalkyl amide or ester compound; method of photostabilising the derivative of dibenzoylmethane L'Oréal (FR) 2008-04-16 EP disclosed
US-20080019930-A1 Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds L'OREAL (FR) 2008-01-24 US disclosed
US-20080019930-A1 Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds L'OREAL (FR) 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080019930-A1 Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds TYR, DDT, AADAC GPR139 4096/4885TSHR 4288/4885NPC1 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.